Cantor Fitzgerald restated their buy rating on shares of HealthEquity, Inc. (NASDAQ:HQY) in a research report sent to investors on Tuesday. They currently have a $56.00 price objective on the stock.

A number of other equities analysts have also commented on the stock. Oppenheimer Holdings, Inc. reissued an outperform rating and issued a $61.00 price target (up previously from $57.00) on shares of HealthEquity in a research report on Monday, June 12th. Chardan Capital lifted their price target on shares of HealthEquity from $53.00 to $57.00 and gave the company a buy rating in a research report on Wednesday, June 7th. Zacks Investment Research raised shares of HealthEquity from a hold rating to a buy rating and set a $54.00 price target on the stock in a research report on Wednesday, July 12th. BidaskClub lowered shares of HealthEquity from a buy rating to a hold rating in a research report on Monday, July 24th. Finally, TheStreet raised shares of HealthEquity from a c rating to a b rating in a research report on Monday, July 31st. One investment analyst has rated the stock with a sell rating, two have issued a hold rating and eleven have given a buy rating to the company. The company presently has a consensus rating of Buy and a consensus target price of $50.22.

Shares of HealthEquity (NASDAQ:HQY) opened at 42.64 on Tuesday. The company has a market capitalization of $2.56 billion, a P/E ratio of 80.15 and a beta of 1.73. HealthEquity has a one year low of $30.34 and a one year high of $54.95. The firm has a 50-day moving average price of $46.03 and a 200-day moving average price of $45.83.

HealthEquity (NASDAQ:HQY) last released its quarterly earnings results on Tuesday, June 6th. The company reported $0.19 EPS for the quarter, beating the Zacks’ consensus estimate of $0.16 by $0.03. HealthEquity had a net margin of 17.04% and a return on equity of 11.61%. The company had revenue of $55.40 million for the quarter, compared to analyst estimates of $54.77 million. During the same quarter last year, the firm posted $0.15 earnings per share. The company’s quarterly revenue was up 25.9% compared to the same quarter last year. Equities analysts forecast that HealthEquity will post $0.60 earnings per share for the current year.

WARNING: “HealthEquity’s (HQY) “Buy” Rating Reiterated at Cantor Fitzgerald” was reported by The Cerbat Gem and is the property of of The Cerbat Gem. If you are accessing this piece on another website, it was illegally copied and republished in violation of U.S. and international trademark & copyright law. The legal version of this piece can be read at https://www.thecerbatgem.com/2017/09/01/healthequitys-hqy-buy-rating-reiterated-at-cantor-fitzgerald.html.

In related news, VP Jon Soldan sold 25,000 shares of the business’s stock in a transaction on Monday, August 28th. The shares were sold at an average price of $40.68, for a total transaction of $1,017,000.00. Following the transaction, the vice president now owns 30,652 shares of the company’s stock, valued at $1,246,923.36. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, VP Darcy G. Mott sold 9,500 shares of the business’s stock in a transaction on Monday, August 21st. The stock was sold at an average price of $42.00, for a total transaction of $399,000.00. Following the transaction, the vice president now directly owns 84,500 shares in the company, valued at approximately $3,549,000. The disclosure for this sale can be found here. Insiders have sold 2,443,821 shares of company stock worth $125,203,393 in the last ninety days. 29.00% of the stock is currently owned by insiders.

A number of institutional investors have recently made changes to their positions in HQY. BlackRock Inc. increased its stake in HealthEquity by 157,852.9% in the first quarter. BlackRock Inc. now owns 5,589,953 shares of the company’s stock worth $237,293,000 after buying an additional 5,586,414 shares in the last quarter. Janus Henderson Group PLC increased its stake in HealthEquity by 627.9% in the second quarter. Janus Henderson Group PLC now owns 2,113,030 shares of the company’s stock worth $105,292,000 after buying an additional 1,822,732 shares in the last quarter. FMR LLC increased its stake in HealthEquity by 45.6% in the second quarter. FMR LLC now owns 2,235,150 shares of the company’s stock worth $111,378,000 after buying an additional 699,728 shares in the last quarter. TimesSquare Capital Management LLC acquired a new stake in HealthEquity during the second quarter worth $25,822,000. Finally, Henderson Group PLC acquired a new stake in HealthEquity during the first quarter worth $12,323,000. 91.86% of the stock is currently owned by institutional investors and hedge funds.

About HealthEquity

HealthEquity, Inc provides a range of solutions for managing healthcare accounts (Health Savings Accounts (HSAs), Health Reimbursement Arrangements (HRAs) and Flexible Spending Accounts (FSAs)) for health plans, insurance companies and third-party administrators. The Company is engaged in technology-enabled services platforms that allow consumers to make healthcare saving and spending decisions.

Analyst Recommendations for HealthEquity (NASDAQ:HQY)

Receive News & Stock Ratings for HealthEquity Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HealthEquity Inc. and related stocks with our FREE daily email newsletter.